Ethosuximide
NDC 59762-2350, Ethosuximide, solution, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-2350
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA080258
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-2350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETHOSUXIMIDE250 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-2350-6 | 59762235006 | 1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-6) / 474 mL in 1 BOTTLE, PLASTIC |
| 59762-2350-7 | 59762235007 | 1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-7) / 474 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/19c924c2-f558-4c78-9277-2d7e0df2f505NADAC price for package 59762235007
GET /v1/drugs/nadac/59762235007
Use it
Look up 59762-2350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-2350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-2350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.